Geisinger, Regeneron to Sequence at Least 5,000 Exomes in '14; Begin Returning Results in Fall | GenomeWeb

A large-scale genomic sequencing study by the Geisinger Health System and Regeneron is expected to sequence at least 5,000 exomes this year and to report medically actionable results back to participants starting this fall, Clinical Sequencing News has learned.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.